GCSAML and hematopoietic and lymphoid cell neoplasm: The methylation statuses at the PARD6G-AS1 and GCSAML iDMRs were perturbed in the methylomes of hematopoietic cancers, with both hypo- and hypermethylated profiles observed in different types of malignancies (Figure 9).